the good tolerability of this drug as well as a decline in theMSRVtranscript levels and stability ofbrain lesions[85]. The extension study throughout the 12months of follow-up also approved the safety of the substance. Moreover, anti-GnbAC1 antibodies were not detected in patients’ sera[86...
effective.In comparison to rituximab injections,inebilizumab displays better tolerance and safety.Moreover,it demonstrates a partial effect in preventing optic nerve atrophy.Thus,it stands as an effective method to reduce the disability rates and improve the daily living ability of patients with N...
Chimeric antigen receptor T cellshave been also developed for the treatment of ALL and other CD19-positivemalignancies[4], but their performance and safety are beyond the scope of this document. Infectious complications associated with their use have been recently reviewed[5]. ...